As deaths from an Ebola virus outbreak in the Democratic Republic of Congo and Uganda have risen above 80, the World Health ...

The FDA has approved AstraZeneca's aldosterone synthase inhibitor (ASI) – baxdrostat – for hard-to-treat hypertension, making ...

Yet, tell the council you’ve moved and you may still need to inform the school, your GP, the DVLA, and a range of other ...

The turmoil at the FDA continues with the news that Tracy Beth Høeg has been fired as acting head of the FDA's Center for ...

Regeneron has reported that its fianlimab antibody targeting LAG-3, an immune checkpoint proposed as a cancer target, has missed the mark in a highly anticipated melanoma trial. The phase 3 trial was ...

Germany's Merck KGaA is looking at making further acquisitions to boost its business, according to chief executive Belén Garijo. The CEO – who is due to step down next April after five years in the ...

AI company Anthropic and the Gates Foundation have said they will provide $200 million in funding for a programme to support the development of AI for "health, life sciences, education, and economic ...

UK Health Secretary Wes Streeting has resigned from Keir Starmer's government, saying he has lost faith in the Prime Minister ...

Khalil Asmar, VP of cardiometabolic health at Lilly UK & Ireland (l), and former England spin bowler Ashley Giles (r). Like ...

Boehringer Ingelheim's alliance with digital health company Brainomix on an AI-enabled tool for diagnosing interstitial lung ...

Big Tech platforms continue to roll out AI health assistants at scale, with Amazon’s new agent the latest to be integrated ...

MSD is scrapping a £1 billion ($1.35 billion) expansion of its UK operations – including a facility already under construction in London – saying the country does not value innovative medicines. The ...